Allergy

Resource Center

Commentary

Research Summaries

FDA Alert

FDA Alert

FDA Approves Dupilumab for Allergic Fungal Rhinosinusitis

02/25/2026

Kate Young

The FDA has approved dupilumab (Dupixent) for the treatment of allergic fungal rhinosinusitis, a rare form of chronic sinus inflammation driven by hypersensitivity to fungal organisms in the sinuses, in...

02/25/2026

Research Summary

Research Summary

Can Daily Moisturizer Use Prevent Atopic Dermatitis in Infants?

08/14/2025

Anthony Calabro, MA

New findings from a large, pragmatic trial found that daily full-body emollient application beginning by 9 weeks of age significantly reduced the cumulative incidence of atopic dermatitis by 24 months. ...

08/14/2025

FDA Alert

FDA Alert

FDA Approves Epinephrine Nasal Spray for Allergic Reactions, Anaphylaxis

08/19/2024

Anthony Calabro, MA

The nasal spray is the first FDA-approved epinephrine product for the treatment of anaphylaxis not to be administered by injection.

08/19/2024

Research summary

Research summary

Clinical Practice Guidelines on Immunotherapy Recommendations for Inhalant Allergy

07/11/2024

Jessica Ganga

The American Academy of Otolaryngology-Head and Neck Surgery Foundation released a set of guidelines that outline evidence-based recommendations on the use of immunotherapy for inhalant allergy for...

07/11/2024

allergy

FDA Approves New Option for Chronic Rhinosinusitis With Nasal Polyps

06/26/2019

The FDA has approved the first treatment option for chronic, inadequately controlled rhinosinusitis with nasal polyps.

06/26/2019

April 2026

Current Issue

April 2026